FdaApplication
NDA 021721
Identifiers
- fda_app_no: NDA021721
Properties
| Property | Value |
|---|---|
| applicant_name | JANSSEN PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2004-10-21 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LEVAQUIN | LEVOFLOXACIN | 250MG/10ML | SOLUTION;ORAL |
1 product